NCT01807793已完成不适用
Targeted Management Intervention for African-American Men With TIA or Stroke.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 43
- 试验地点
- 2
- 主要终点
- Medication adherence
研究概览
简要总结
Stroke is the leading cause of disability, third leading cause of death, and one of the most resource-intensive diseases among Americans. African-Americans (AA) have a stroke rate nearly double that of Euro-Americans (EA), and AA who experience a first-ever stroke are younger, have greater stroke disability, more post-stroke complications, and slower recovery compared to EA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 22 Years 至 64 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Self-identified AA male
- •Between 22 and 64 years of age (> age 21 and < age 65).
- •Within 6 months of discharge for Stroke /TIA
- •Planned or recent home discharge
- •Barthel Index (BI) score of > 60
- •Available care partner willing to participate
- •Be able to speak and understand English
排除标准
- •Individuals who are unable or unwilling to provide written informed consent
结局指标
主要结局
Medication adherence
时间窗: Screening/baseline, 3 months, 6 months
The primary outcome will be change in medication treatment adherence with stroke risk reduction pharmacotherapies as measured by the Tablets Routines Questionnaire (TRQ)
次要结局
- Biological and health behaviors parameters(Baseline, 3 months, 6 months)
研究者
Martha Sajatovic, MD
Professor
University Hospitals Cleveland Medical Center
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic FactorsEndovascular ThrombectomyIschemic StrokeStrokeNCT05708079Fondazione Policlinico Universitario Agostino Gemelli IRCCS600
已完成
不适用
A Community Partnership to Treat StrokeStrokeNCT01499173University of Michigan101
已完成
不适用
Combined Neural and Behavioral Therapies to Enhance Stroke RecoveryStrokeNCT00929656VA Office of Research and Development22
已完成
不适用
"Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic StrokeStrokeNCT00792220University Hospital, Saarland200
已完成
2 期
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic StrokeAcute Ischemic StrokeNCT04309474AbbVie121